Kyros Law LLP has a proven track record in fighting for shareholder rights in merger and acquisition deal cases. Below you will find some recent merger and acquisition actions that have been handled by Kyros Law on behalf of shareholders.
- Solutia Systems (SOA) - Representation of shareholder interests in $3.38 billion dollar Eastman Chemical purchase of Solutia, a St Louis based company that makes specialty chemicals used in the automotive and architectural industries.
- Pacific Capital Bancorp (PCBR) - $1.51 Billion dollar bank buyout, representation of stock holders in purchase by Japanese based UnionBanCal.
- New Frontier Communications (NOOF) - Representation of shareholders in proposed $20 million dollar buyout of pay per view company by Longkloof.
- Merisel - Shareholder represented in Delaware courts in offer that would take National Graphic Design company private.
- Novellus Systems - Representation of shareholder in $3.3 billion dollar semiconductor company deal. Case filed in California.
- Openlane (OPNN) - Being acquired by KAR Auction Services Inc for $210 million, the companies operate wholesale online auto auction services. Lawsuit filed to get adequate proxy and disclosures from the Open Lane.
- China ACM - Unfair Buyout Offer. Representation of shareholder with over 500,000 shares. Lawsuit Filed alleging too low share price offer.
- Motorola Mobility (MMI) - Google offer to Takeover Motorola for 12 Billion. Lawsuit filed, many questions by Motorola shareholders.
- PAETEC Holding Corp - Offer to buyout Paetec shareholders for $891 Million by Windstream. Lawsuit filed on behalf of small investor.
- Medco Health Solutions - one of the largest transactions of 2011 a 29 Billion dollar deal involving a pharmacy services company that serves 65 million people, acquired by Express Scripts Inc. Lawsuit filed in Delaware.
- Petrohawk Energy - a 12 Billion dollar buyout of an oil exploration company by a Large oil company. Lawsuit filed in Delaware.
- Icagen - a $56 million dollar buyout of a bio-drug company by Pfizer. Lawsuit brought in Delaware.